共 50 条
- [41] AKATHISIA PROFILE OF ILOPERIDONE IS SIMILAR TO PLACEBO: RESULTS FROM A POOLED ANALYSIS OF 2 PHASE III CLINICAL TRIALSSCHIZOPHRENIA BULLETIN, 2011, 37 : 29 - 30Weiden, Peter J.Citrome, L.Hochfeld, M.Meng, X.
- [42] Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDEOPHTHALMOLOGY, 2012, 119 (04) : 789 - 801Quan Dong NguyenBrown, David M.Marcus, Dennis M.Boyer, David S.Patel, SunilFeiner, LeonardGibson, AndreaSy, JudyRundle, Amy ChenHopkins, J. JillRubio, Roman G.Ehrlich, Jason S.
- [43] Efficacy and safety of itopride in functional dyspepsia: Results of two phase III multicentre, randomized, double-blind, placebo-controlled trialsGASTROENTEROLOGY, 2007, 132 (04) : A93 - A93Talley, Nicholas J.Tack, JanPtak, TheadoreGupta, RajendraGiguere, Monique
- [44] Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: results from two phase III, randomized, double-blinded, placebo-controlled trialsBRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E97 - E98Silverberg, Jonathan I.Thaci, DiamantSeneschal, JulienGold, Linda SteinBlauvelt, AndrewSimpson, EricChu, Chia-YuLiu, Zhuqing T.Lima, Renata GontijoPillai, SreekumarGuttman-Yassky, Emma
- [45] Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)Abou-Alfa, Ghassan K.Meyer, TimCheng, Ann-LiiEl-Khoueiry, Anthony B.Rimassa, LorenzaRyoo, Baek-YeolCicin, IrfanMerle, PhilippePark, Joong-WonBlanc, Jean-FredericBolondi, LuigiKlumpen, Heinz JosefChan, Stephen LamDadduzio, VincenzoHessel, ColinBorgman-Hagey, Anne E.Schwab, GiselaKelley, Robin Kate
- [46] Effect of Linaclotide on Quality of Life in Adults With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase III TrialsGASTROENTEROLOGY, 2010, 139 (01) : E19 - E19Carson, Robyn T.Tourkodimitris, StavrosMacDougall, James E.Lewis, Barbara E.Shiff, Steven J.Lavins, Bernard J.Kurtz, Caroline B.Lembo, AnthonyJohnston, Jeffrey M.
- [47] Pooled safety and efficacy results from two phase III trials comparing briakinumab with etanercept and placebo for the treatment of moderate to severe psoriasisJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB146 - AB146Strober, BruceGottlieb, AliceWilliams, DavidGu, Yihua
- [48] Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled TrialsARTHRITIS & RHEUMATOLOGY, 2017, 69 (02) : 362 - 375Clowse, Megan E. B.Wallace, Daniel J.Furie, Richard A.Petri, Michelle A.Pike, Marilyn C.Leszczynski, PiotrNeuwelt, C. MichaelHobbs, KathrynKeiserman, MauroDuca, LilianaKalunian, Kenneth C.Galateanu, CatrinelBongardt, SabineStach, ChristianBeaudot, CarolynKilgallen, BrianGordon, Caroline
- [50] Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study (vol 81, pg 17, 2017)EUROPEAN JOURNAL OF CANCER, 2018, 100 : 135 - 136Chau, IanPeck-Radosavljevic, MarkusBorg, ChristopheMalfertheiner, PeterSeitz, Jean FrancoisPark, Joon OhRyoo, Baek-YeolYen, Chia-JuiKudo, MasatoshiPoon, RonniePastorelli, DavideBlanc, Jean-FredericChung, Hyun CheolBaron, Ari D.Okusaka, TakujiBowman, L.Cui, Zhanglin LinGirvan, Allicia C.Abada, Paolo B.Yang, LingZhu, Andrew X.